Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) transferred its stock listing to the Nasdaq Global Market this month after meeting stricter exchange requirements tied to market capitalization, liquidity, and …
Palvella Joins Nasdaq Global Market as Pipeline Advances Read More
MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) reported modest first-quarter revenue growth as accelerating European sales helped offset slower product mix trends in the United States.
TELA Bio Expands Europe Sales as U.S. Growth Slows Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported higher first-quarter revenue and accelerating demand for its YCANTH treatment as the company advances late-stage clinical trials that could significantly …
Verrica Expands YCANTH Sales as Wart Trials Advance Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) reported double-digit revenue growth in the first quarter as recurring subscription sales and demand from infrastructure and resource-sector customers continued to expand.
Bentley Revenue Rises as Infrastructure Software Demand Grows Read More MALVERN, PA — TELA Bio (Nasdaq: TELA) granted restricted stock units covering 89,250 shares to 12 newly hired employees as the medical device maker continues expanding its commercial operations and …
TELA Bio Expands Workforce With Nasdaq Equity Grants Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) said it remains on track to submit a New Drug Application in the second half of 2026 for QTORIN rapamycin after reporting …
Palvella Eyes 2027 Launch After Positive Phase 3 Results Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS) outlined plans for multiple mid- and late-stage clinical milestones this year as the biotechnology company advances experimental treatments for asthma, atopic dermatitis …
Aclaris Expands Immunology Pipeline Ahead of Key Trial Data Read More
MALVERN, PA — Ocugen (NASDAQ: OCGN) reported positive mid-stage clinical data for its geographic atrophy gene therapy program while raising additional capital expected to fund operations into 2028 as the …
Ocugen Reports Positive GA Trial Data, Extends Cash Runway Read More
MALVERN, PA — Neuronetics (NASDAQ: STIM) reported higher first-quarter revenue driven by growth in its U.S. clinic operations following the Greenbrook acquisition, while the company narrowed losses and reduced cash …
Neuronetics Revenue Rises as Clinic Business Expands Read More
MALVERN, PA — Meridian Corporation (Nasdaq: MRBK) revised its first-quarter earnings after learning of a change in the status of a participated loan following the company’s original April 23 earnings …
Meridian Revises Earnings After Loan Status Change Read More